'A Theranos With Zero Technical Innovation': The Case for Transparent DTC Blood Testing
AaronBergman18 · x · 2026-10-20
The author floats an ironic startup idea: a 'Theranos with no technical innovation whatsoever'—a plain direct-to-consumer blood test service where you pick tests from a transparent priced menu, pay out of pocket, and get your blood drawn. The point is a jab at opaque healthcare: transparent, simple lab testing without any miracle-tech claims.
More from Venture
- AI data brokering splits: pre-training data commoditizes, RL post-training data is the real business — agihouse_org · 2026-10-20
- NSF should spend $100M seeding AI resilience startups, argues AI Frontiers brief — luke_drago_ · 2026-10-20
- Dyna Robotics crosses ROI threshold as Din Tai Fung expands robot deployment with bigger contract — JasonMa2020 · 2026-10-20
- Indie dev's vibe coded games on spawn hit 20K+ weekly players — TAbrodi · 2026-10-20
- OpenAI, Google, AWS are pouring billions into embedded-engineer services arms — alex_verem · 2026-10-20
- Founder offers to build business websites in 30 minutes on a call: 'questions are the only moat left' — StewartalsopIII · 2026-10-20